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Abstract Most studies and reviews on robots for neu-
rorehabilitation focus on their effectiveness. These studies
often report inconsistent results. This and many other
reasons limit the credit given to these robots by therapists
and patients. Further, neurorehabilitation is often still based
on therapists’ expertise, with competition among different
schools of thought, generating substantial uncertainty about
what exactly a neurorehabilitation robot should do. Little
attention has been given to ethics. This review adopts a
new approach, inspired by Asimov’s three laws of robotics
and based on the most recent studies in neurorobotics, for
proposing new guidelines for designing and using robots
for neurorehabilitation. We propose three laws of neuro-
robotics based on the ethical need for safe and effective
robots, the redefinition of their role as therapist helpers, and
the need for clear and transparent human–machine inter-
faces. These laws may allow engineers and clinicians to
work closely together on a new generation of neurorobots.
Keywords Rehabilitation  Robotic training 
Neuroscience  Ethics  Medical robots
1 Introduction
1.1 Controversial Effectiveness of Robots
for Neurorehabilitation
The first robots used for neurorehabilitation were devel-
oped in the 1980s [1, 2], their potential was claimed in the
1990s [3–5], and robotic exoskeletons started to spread in
the 2000s [6, 7]. However, their is still debate on the
effectiveness of robots in neurorehabilitation.
Contrasting results were obtained in different studies
about neurorehabilitation robot efficacy [8–11], even
though the results of some randomized controlled trials
performed on wide samples showed significant improve-
ments in the outcome of robot-assisted therapy with respect
to usual care [12, 13]. Meta-analyses have only partially
helped in clarifying the objective effectiveness of robotic
training, with most results being inconclusive. A 2008
Cochrane review on post-stroke arm training robots [14]
concluded its analysis on 11 studies (328 subjects) by
stating that: ‘‘patients who receive electromechanical and
robot-assisted arm training after stroke are not more likely
to improve their activities of daily living, but arm motor
function and strength of the paretic arm may improve’’.
The same authors further updated their Cochrane review in
2012 [15], including 19 trials (666 subjects), concluding:
‘‘Patients who receive electromechanical and robot-assisted
arm training after stroke are more likely to improve their
generic activities of daily living. Paretic arm function may
also improve, but not arm muscle strength’’. These results
were hence in opposition with those obtained previously.
Although the second Cochrane review should be consid-
ered more reliable, given the higher number of trials and
enrolled subjects, the contrasting results (also in terms of
muscle strength) lead to confusion.
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Cochrane reviews on walking rehabilitation performed
using robots also provide inconsistent results. A Cochrane
review, as well as its update [16, 17], reported higher
probability of recovery in patients who receive elec-
tromechanical-assisted gait training in combination with
physiotherapy, whereas another Cochrane review [18]
reported similar recovery probabilities for patients with and
without treadmill training (i.e., with and without body
weight support).
Besides effectiveness, three other aspects deserve
attention. Firstly, these Cochrane reviews analysed elec-
tromechanical devices and robots as a single and homo-
geneous field. In fact, electromechanical devices developed
for neurorehabilitation (e.g., treadmill with body weight
support or Gait Trainer (Reha-Stim, Berlin, Germany)) are
often but improperly considered members of the robot
family [19]. This is a major concern for the designers of
robot-therapy systems, who have failed so far to provide a
comprehensive and agreed-on framework for the correct
classification of these devices [20]. A second aspect
deserving attention is that many studies about the efficacy
of specific devices were published after their commercial-
ization. This approach is inconceivable in other medical
fields, for example pharmacology. The third point to take
into account is that effectiveness should be referred not
only to the device per se, but also to the specific patient
groups targeted by the therapy [21–23], and to the timing
and protocol adopted for that device [24]. This point was
highlighted by Mehrholz et al. [16]: the correct use of new
technologies must rely on the information regarding the
types of patients and the phase of rehabilitation that will
benefit from specific technologies. For example, patients
with more severe impairments in the motor leg can benefit
more from robotic-assisted therapy, in combination with
conventional therapy, than from conventional therapy
alone. This likely occurs because, in the case of very
impaired patients, robotic devices, increase the therapy
intensity with respect to conventional ones [21, 22]. Con-
versely, patients with greater voluntary motor function in
the affected limb can perform intensive training also in
conventional therapy. For these patients, neurorehabilita-
tors may prefer less constrained, more ecological, and more
variable exercises [25]. Physical condition is not the only
factor determining the best class of neurorobot users: the
patient psychological profile can also be important in
attaining superior motor outcomes with robot training
compared to conventional therapy [24].
These results have led to a proposal of a change in the
research question about the effectiveness of robot devices:
‘‘instead of asking ourselves whether robotic devices are
effective in rehabilitation, we should determine who will
benefit more from robotic rehabilitation’’ [25]. Inclusion
and exclusion criteria are not the only characteristics to be
determined in the design of a rehabilitation protocol when a
robot is used. Few studies have focused on the definition of
guidelines for an effective selection of movement param-
eter values (such as joint angles, speeds, applied forces, and
torques) and for better timing of robot therapy adminis-
tration, both tailored on the patient’s capacities and needs.
However, before further discussing the issue of effec-
tiveness, and the reasons of the limited credit that is given
to neurorobots, it is fundamental to clarify the difference
between robots and electromechanical devices by defining
what a neurorobot is.
1.2 What is a Neurorobot?
Some cooking machines are commonly called robots by
manufacturers and end-users. However, no one calls a
mixer a robot. This does not depend on machine com-
plexity: a car is usually more sophisticated than a cooking
machine, but no one considers cars to be robots. In contrast,
clinicians and sometimes neuroscientists often confound
electromechanical devices with robots [20].
The word ‘‘robot’’ first appeared in 1921 in a science
fiction play titled R.U.R. (Rossum’s Universal Robots)
written by the Czech author Karel Capek. It derives from
the Czech word ‘‘robota’’, meaning hard workers [19, 26].
The robots invented by Capek were not robots in the
popularly understood sense of mechanical devices; instead,
they were assembled biological organisms. However, the
term has since come to signify primarily electromechanical
devices (often humanoid) endowed with artificial intelli-
gence and able to perform a variety of functions, partly
through programming and partly through their own ability
to act autonomously [27]. According to that, the Robot
Institute of America defined a robot as ‘‘a programmable,
multi-functional manipulator designed to move material,
parts or specialized devices through variable programmed
motions for the performance of a variety of tasks’’ [28].
Neurorobotics refers to the branch of science combining
neuroscience, robotics, and artificial intelligence. It hence
refers to all robots developed for interacting with or for
emulating the nervous system of humans or other animals.
A neurorobot can be developed for clinical purposes, for
example neurorehabilitation or neurosurgery, or for
studying the nervous system by emulating its properties, as
it occurs for example in the walking robots based on central
pattern generators [29].
As mentioned above, a robot should be capable of per-
forming a variety of tasks. This adaptability is based on its
on-board sensors, the signals of which are processed by
artificial intelligence to change the behaviour of the robot.
Hence, the fundamental point differentiating robots from
electromechanical devices is the adaptability of their
operation. In neurorehabilitation, this differentiation has
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often been considered as picky, and robots and elec-
tromechanical devices are often grouped together during
analyses of their efficacy [19]. Treadmills with body
weight support and other devices such as Gait Trainer
(Reha-Stim) should be defined as electromechanical devi-
ces, because, once the physiotherapist has fixed their
parameters, they are not capable of autonomously adapting
them during operation. Conversely, other devices devel-
oped for walking recovery, such as Lokomat (Hocoma,
Volketswil, Switzerland), can be defined as robots since
they use sensors to adapt their functioning to the patient’s
performance (e.g., Lokomat has a position control mode for
applying an assistance-as-needed guidance force to the
lower limbs).
1.3 Features of Neurorehabilitation Robots
Many neurorehabilitation approaches and techniques have
been developed to restore neuromotor function, aiming at
the recovery of physiological movement patterns in
patients with neurological pathologies. However, none has
emerged as a gold standard, since it is common opinion
that methods should be specifically tailored for pathologies
and patients [30]. However, a common feature of these
neurorehabilitative approaches is the need for intensive,
repetitive, and task-oriented treatments [25].
Many authors reported that robots can improve reha-
bilitation outcome. In 2008, Wolbrecht et al. [31] identi-
fied three main desirable features for a controller of robot-
aided movement training (see Table 1). One year later,
Morasso et al. [20] re-stated these features, adding the
importance of haptic properties and auto-adaptive capac-
ities. Then, Belda-Lois et al. [30] suggested four features
for favoring a top-down approach when a robot is used for
post-stroke gait recovery. Finally, Dietz et al. [32]
reported four main potential advantages of the use of
robots in neurorehabilitation. All these features are listed
in Table 1.
The features indicated by Wolbrecht et al. [31] mainly
focused on the need of adaptability of neurorobots to
patients’ abilities. Morasso et al. [20] added that a robot
must have also haptic properties and some intelligent
capabilities related to an adaptive assist-as-needed
approach. Both studies highlighted the importance of a
high mechanical compliance, i.e., the need of having a
robot with low-stiffness control. A stiff position controller,
such as that of industrial robots, can move limbs along the
desired trajectories, limiting errors. However, such a con-
troller impedes error-based learning, which is an essential
component of motor re-learning [20]. Furthermore, a low-
stiffness robot is potentially less dangerous than a high-
stiffness robot during interaction with the patient [20]. Two
other studies [30, 32] focused on the importance of inten-
sive (for patients, not therapists) and repeatable exercises.
Both pointed out the possibility of exploiting robot sensors
not only to adapt to the patient’s performance, but also to
provide biofeedback to the patient (increasing his/her
motivation and hence participation in rehabilitation), and
feedback to therapists and clinicians on patient progress.
Neurorobots have the potential for accurate assessment
of motor function in order to assess the patient status, to
measure therapy progress, or to give the patient and ther-
apist real-time feedback on movement performance [33].
This approach has been proposed in some recent studies.
Kinematic robotic measures, especially those related to
range of motion, have recently been indicated as useful in
the assessment of motor deficits in reaching movements
[34] and proprioceptive function of hands [35] and upper
[36] and lower [37] limbs. Furthermore, kinetic robotic
measures have been reported as useful in the assessment of
upper limb strength [33].
It should be noted as among these features, effectiveness
is not listed, probably because it is taken for granted when
training is performed in a patient-tailored, intensive,
repetitive, and task-oriented manner; however, this issue
deserves further attention.
Table 1 Ideal features of neurorobot
Wolbrecht et al. [29] Morasso et al. [18] Belda-Lois et al. [28] Dietz et al. [30]
High mechanical compliance High mechanical compliance Repeatability Standardized training sessions
Ability to assist patients in
completing desired movements
Large range of force Increased training motivation through
use of interactive (bio)feedback
Intensive training
Minimum assistance level Minimum assistance level Precisely controllable assistance or
resistance during movements
Relieves therapist from physically
demanding work
Soft haptic interaction for
proprioceptive awareness
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1.4 Effectiveness Paradox in Neurorobotics
Morasso et al. noted a paradox in the assessment of
effectiveness of neurorehabilitation robots [20]. Most
studies have suggested that robotic treatment should be
highly personalized by setting the robot parameters in order
to exploit the residual capabilities of each patient for
recovering a functional status. This implies that in order to
be effective, robotic treatment cannot be standardized, and
therefore controlled clinical trials in the traditional sense
are impossible, unless aimed at very specific and narrow
groups (implying a small sample size, hence poor statistical
evidence). The contrast between a standardized treatment
(with clear guidelines) allowing the design of a randomized
controlled trial (and of clear rehabilitative programmes)
with an adaptable treatment, tailored for patients’ capa-
bilities, is the core of this effectiveness paradox. Further-
more, the contrast between standardization and adaptability
is not the only problem in designing a methodologically
rigorous study. Intensive training may increase the risk of
inducing or augmenting spasticity. In addition, the
monotony of the same exercise with identical trajectories
clashes with the need for continuous adaptation of robots to
the changing abilities of patients and with the need for
motivating, rather than boring, exercises. Finally, most
robots help patients in reproducing a movement that
replicates the physiological one, despite the fact that most
severely affected patients have a low possibility of a
complete recovery.
It should be noted that these inconsistencies are present
also in conventional neurorehabilitation training. The sci-
entific bases of neuromotor physiology, neurorehabilita-
tion, and brain plasticity are still not completely clear.
Neurorehabilitation is still mainly ill-defined, with com-
peting schools of thought about the best treatment.
This generates another scientific roadblock for neuro-
robots. In fact, neither the optimal movement tasks nor the
optimal mechanical inputs are well known. Therefore, the
first problem that a robotics engineer encounters when
setting out to build a robotic therapy device is that there is
still substantial uncertainty as to what exactly the device
should do [38], despite the above-cited general features
suggested in the literature.
Interestingly, the scepticism related to neurorobotics due
to the rather inconclusive evaluation of its efficacy and to
the reported inconsistencies is not mitigated by the con-
sideration that quite similar evaluations could be formu-
lated for the variety of human-delivered rehabilitation
techniques [20]. Thus, the doubts about the use of neuro-
robots could be not only attributed to the uncertainty
related to efficacy, but also to some other barriers limiting
their wider adoption in rehabilitative settings.
1.5 Other Barriers Limiting Neurorobotics
Other aspects limiting neurorobotics are due to techno-
logical, behavioural, and economic barriers [39]. Initial
economic burden is a potential limit for robot adoption in
neurorehabilitation, although it has been reported that the
long-term use of neurorobots can decrease healthcare sys-
tem costs [20]. For example, a single physiotherapist could
manage up to four robots (hence four patients) at the same
time [25]. Masiero et al. [40] quantified the cost of using
NeReBot (a robot for the treatment of post-stroke upper
limb impairment) to be 37 % of the hourly physiotherapy
cost, with benefits that include a reduction in hospitaliza-
tion time. This suggests that robotic technology can be a
valuable, and an economically sustainable aid, in the
management of patient rehabilitation. Hesse et al. found a
similar percentage (41 %) under the assumption that the
therapist is needed only at the beginning and end of ther-
apy, and in particular situations where help is needed [41].
In general, rigorous studies on the economic sustainability
of robots for neurorehabilitation are very sporadic [42].
These few studies suggest that robotic therapy leads to a
reduction of costs for the healthcare system, in terms of a
reduction in the hospitalization for each patient, higher
autonomy at discharge, or both. However, as highlighted
by Turchetti et al. [42], an individual hospital could be less
interested than the final payer (e.g., the national or local
healthcare system, the private patient, or the insurance
companies) in these aspects. However, this clearly depends
on the reimbursement regimen and on the agreement
between the parties. In general, uncertainty remains about
the cost-effectiveness of robotic neurorehabilitation [43].
Technological and behavioural aspects could be related
to the possibility that the expectations of patients and
clinicians about outcomes of a neurorobotic treatment are
too high with regards to the current biomedical engineering
level. These reasons seem conceivable, but raise another
question: why have such expectations not limited other
kinds of medical robot, such as surgical robots? In fact,
although surgical robots were introduced at around the
same time as neurorehabilitation robots, their benefit in
assisting surgery (and especially minimally invasive sur-
gery) is established. Even in fields with no unequivocal
evidence of the superiority of robot-assisted over tradi-
tional surgery, the popularity and diffusion of robotic sur-
gery has progressively increased [44]. In the last 25 years,
robots have brought a tremendous improvement to the field
of surgery [45]. Thus, other reasons should be investigated
to deeply understand what is still lacking for neuroreha-
bilitation robots in order to match the expectations of
patients and clinicians. In this scenario, an irrational aspect
seems to play a fundamental role.
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1.6 Fear of Robots
In the play of Capek, robots are initially obedient, and,
when commanded, they perform the required task, by
exactly following human instructions. The robots eventu-
ally escape human control and start a rebellion. This theme
is similar to the Jewish myth of the Golem of Prague (an
animated anthropomorphic being entirely created from
inanimate matter) and is used in many science fiction
works. Could fear actually play a role in the scepticism
towards neurorobots?
In general, studies that used questionnaires to collect the
opinions of users (patients and therapists) of neuroreha-
bilitation robots reported good usability, comfort, accept-
ability, and satisfaction. However, most were feasibility
studies that enrolled healthy subjects [46], fewer than 10
patients [47–51], or lacked a control group undergoing
conventional physiotherapy [52, 53]. Even when a control
group was used, only the satisfaction of experimental
physiotherapy was assessed [54]. Hence, these positive
results should be read with caution, since they were
obtained on a small group of users, often not randomly
assigned to robotic therapy. Furthermore, these results can
generate a bias, since the patients, who accepted to undergo
robotic therapy, could be more trustful with regards to the
use of new technological rehabilitation interventions.
In 2000, Burgar et al. reported their experience in
developing robots for neurorehabilitation, concluding their
work with ‘‘we do not view robots as replacements for
therapists’’ [55]. However, most of the initial studies on
robots claimed that robotic devices can reduce the number
of therapists and the associated costs needed for rehabili-
tation [25, 56, 57] (despite the existence of cases in which
two physiotherapists are required for preparing the most
severely affected patients for robotic neurorehabilitation,
which is typically the case when harnessing the patient on
robots for walking recovery based on body weight support
[24]).
Furthermore, in terms of control, the patient’s feelings
related to robot use in neurorehabilitation should also be
considered. Bragoni et al. [23] identified the level of anx-
iety of patients as a negative prognostic factor for robotic
therapy but not for conventional therapy. In contrast,
patients who saw themselves as the chief causal factor in
managing their recovery showed higher probability of a
better outcome with robotic rehabilitation [23]. This kind
of fear could be due to the sensation that robots are not
considered trustworthy because they lack human feelings,
expertise, and common sense [57]. This is one of the
hardest problems in artificial intelligence and robotics
faced by bioengineers.
2 Three Laws of Neurorobotics
2.1 Three Laws of Robotics
After the play of Capek, robots became iconic, especially
thanks to Isaac Asimov’s stories, and to his compilation ‘‘I,
Robot’’ in 1950 [58]. In a story included in that compila-
tion and first published in 1942 titled ‘‘Runaround’’, Asi-
mov invented the three laws of robotics, quoted as being
from the ‘‘Handbook of Robotics, 56th Edition, 2058’’.
These rules are a set of fundamental requirements for the
design and manufacture of intelligent robots. They are
intended to ensure that robots will operate for the benefit of
humanity, rather than becoming a threat to humans. These
laws had a very influential role in subsequent science fic-
tion works, and became also important with the emergence
of robotics as a scientific discipline [59]. The three laws of
robotics are:
(1) A robot may not injure a human being or, through
inaction, allow a human being to come to harm.
(2) A robot must obey the orders given it by human
beings, except where such orders would conflict with
the First Law.
(3) A robot must protect its own existence, as long as
such protection does not conflict with the First or
Second Laws.
These laws define a kind of set of ethic rules for robots
(or for the human programmers of their artificial intelli-
gence). The hierarchical structure of these laws places at
the first level human health, followed by human will, and
finally robot self-preservation. These laws should not be
considered only as part of science fiction imagery. Their
potential role is so important that they have been re-ana-
lyzed in the current context, in the Editorial of a Special
Issue of Science, entitled ‘‘Robot Ethics’’ [60]. In this
editorial, Sawyer stated that, since the U.S. military is a
major source of funding for robotic research, it is unlikely
that such laws will be integrated in their design. This
argument can be generalized to cover other robotic indus-
tries: the development of artificial intelligence is a busi-
ness, and businesses are usually uninterested in ethical
issues. The risk, in the neurorehabilitation field, is that
companies may produce attractive robots without proving
their effectiveness. The potential risks related to the use of
medical robotics deserve attention: harm may occur from
anomalous functioning, or even from normal robot beha-
viour [57]. If many of the problems related to neurorobots
are related to fear, risks, and ethical issues, it is probably
time to define a set of rules for neurorobot ethics before
defining their desirable features.
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2.2 Three laws of neurorobotics
According to the aforementioned desirable features of a
neurorobot, we have re-formulated the three laws of
robotics into three laws for robotics in neurorehabilitation:
(1) A robot for neurorehabilitation may not injure a
patient or allow a patient to come to harm.
(2) A robot must obey the orders given it by therapists,
except where such orders would conflict with the
First Law.
(3) A robot must adapt its behavior to patients’ abilities
in a transparent manner as long as this does not
conflict with the First or Second Law.
These laws and their implications are discussed below.
3 Discussion
3.1 First Law of Neurorobotics: Need for High
Benefit/risk Ratio
Personal care robots (e.g., mobile servant robots, physical
assistant robots, and person carrier robots) should be
designed in accordance with the international standards
defined by ISO 13482:2014 [61]. In 2014, the International
Organization for Standardization published these criteria
for designing personal care robots, providing the needed
requirements to eliminate or reduce the risks associated
with the use of medial robots to an acceptable level. ISO
13482:2014 is more specific for personal care robots,
including neurorobots, than the previous ISO14971:2000
[62]. ISO 13482:2014 can be considered to be in line with
the first law of Asimov, with ‘‘harm’’ referring to that to the
patient. Datteri [52], in a review about responsibility in
using medical robots (including surgery and diagnostic
robots, neurorehabilitation robots, robotic prostheses, and
even next-generation personal assistance robots), stated
that these devices operate in close proximity or direct
physical contact with humans, manipulate instruments
inside the patient’s body or directly move user’s impaired
limbs, and have invasive or non-invasive connections with
the human nervous system. They can hence contribute to
improving the precision of medical treatments, relieving
therapists of tasks that require considerable accuracy and
physical effort, and improving the quality of life of patients
[63]. Nevertheless, they also may threaten the physical
integrity of patients, not only through harmful events
caused by anomalous behaviours (e.g., in surgery), but
even through normal operation [57]. This can typically
occur for neurorehabilitation robots whose efficacy has not
been proven [57]. Datteri’s review gives the example of
Lokomat, showing that, despite its diffusion in many
rehabilitation centers, there is neither well-supported
experimental nor theoretical evidence that Lokomat-based
therapies are at least as beneficial as conventional thera-
pies. Instead, the review gives examples of studies that
showed that Lokomat reproduces abnormal and non-
physiological gait patterns due to the restriction of pelvis
movement, altering lower limb joint kinematics [64] and
muscle activations [65]. This limitation has recently been
overcome in LokomatPro (Hocoma) by the addition of an
optional module that allows lateral translation and trans-
verse rotation of the pelvis, aiming at a more physiological
movement. However, it is still unclear if training based on
physiological movement is the optimal solution for patients
severely affected and probably unable to completely
recover physiological patterns. In fact, recovery of auton-
omy in walking should be the objective of robotic gait
rehabilitation, where recovery of physiological gait pat-
terns is not mandatory.
Neurorobots should be safe not only in terms of move-
ment, but also from other medical points of view. For
example, despite the variety of gait patterns, robotic gait
training performed with body weight support has only
recently been proven safe for training intensive walking in
non-autonomous ambulatory patients with subacute stroke.
The reason is that the cardio-respiratory demand is lower
than that in conventional walk training performed over-
ground [66]. Interestingly, the authors found the opposite
result for healthy subjects: overground walking was less
demanding than robotic walking. They suggested that this
could have been because the robot imposes non-natural
trajectories, which force subjects to activate non-natural
sensorimotor walking patterns.
We would like to enlarge the meaning of ‘‘harm’’ to all
possible damage to patients. Time spent on an ineffective,
slightly effective, or even detrimental robot should be
considered as damage, because the patient could spend the
same time in a more effective treatment. Hence, the first
law implies that robot usage should be at least as safe and
effective as other treatments, meaning that it should have a
higher benefit-risk ratio than that of human-administered
treatments. This ratio should be evaluated before com-
mercialization of the device, and not afterwards, as is often
done currently.
But how can a robot be effective in the light of the cited
effectiveness paradox and in the absence of a clear scientific
background? Firstly, it is probably time to delay the com-
mercial launch of neurorobots until a deep examination of
their potential effectiveness is conducted, adopting an
approach more similar to that used in other medical or
engineering disciplines. For example, specific rules are
defined for clinical trials prior to drug commercialization
(Table 2). These trials require Phase I, (commonly per-
formed in the producer laboratories), followed by Phases II
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and III (performed in independent hospitals), before com-
mercialization can occur. Further, Phase IV follows in clin-
ical or daily living settings. Dobkin redefined these phases
for motor rehabilitation treatments [67] (refer to Table 2),
and we suggest that a similar roadmap should be followed by
companies before commercialization of neurorobots (that
should occur only after an equivalent Phase III).
Furthermore, for neurorehabilitation robots, there is still
a lack of clear information about how to administer robotic
therapy, proper use, treatment duration and frequency,
precautions, possible side effects, etc. However, the
effectiveness of a treatment (including that with a neu-
rorehabilitation robot) depends on the patient characteris-
tics (e.g., type and severity of disease, presence of specific
deficits) [16], on the duration and frequency of sessions to
administer, and on the correct phase of rehabilitation at
which the therapy should be administered [25]. For
example, Morone et al. reported that patients with more
severe impairments in the motor leg benefited more from
robotic-assisted therapy than did patients with greater
voluntary motor function in the affected limb, who can
perform intensive and less constrained training in con-
ventional therapy [21, 22]. Unfortunately, neurorobot
handbooks are at the moment still similar to generic
commercial pamphlets, far from drug information sheets.
3.2 Second Law of Neurorobotics: Tool
for Therapists
Some therapists see a robot as a possible substitute for their
work. Morasso et al. thus titled their review on robots for
rehabilitation ‘‘Desirable features of a ‘humanoid’ robot-
therapist’’ [20]. Hidler et al. emphasized that the goal of
introducing robots into rehabilitation hospitals is not to
replace therapists, but rather to complement existing
treatment options [56]. Nevertheless, it is reasonable to
believe that the reduction of healthcare costs is at least one
of the main motives driving research in neurorobotics [57],
given that many studies have reported that robots may
reduce the cost of rehabilitation by reducing the number of
required therapists [25, 56, 57].
The higher popularity of neurosurgery robots compared
to neurorehabilitation robots is thus likely due to the fact
that the former do not replace the surgeon, but aid him.
Similarly, a robot for rehabilitation should not be consid-
ered as a standing-alone rehabilitation device [68], but a
tool in the hands of therapists, giving them more precise
movements, more intensive, repeatable, or adaptable pat-
terns, according to the therapists’ expertise, and relieving
them from fatigue. The therapist should therefore be
included in the loop, in order to drive the symbiotic equi-
librium between robot and patient towards an optimum, by
dialoguing with the patient, motivating them, and getting
verbal feedback on fatigue, pain, and emotional stress
(parameters difficult to monitor with sensors) [57].
Recently, the need for a therapist as motivator to avoid the
patient having a passive role during robotic therapy has
been overcome by a top-down approach of robots com-
bined with stimulating biofeedback, video-game-based
therapy, and even brain-computer interfaces [19, 30].
However, a therapist should play a key role in terms of
robotic therapy administration, such as robot parameter
adjustments, avoiding harmful patient compensation
strategies, identification of the trade-off between chal-
lenging tasks that help rehabilitation and those that
demoralize patients.
To this end, we propose to extend the loop proposed by
Morasso et al. [20] to include the therapist (see Fig. 1). In
our opinion, the desired reduction of costs for the health-
care system can be obtained not by reducing the number of
therapists, but increasing the efficacy of rehabilitation,
reducing the length of stay in rehabilitative hospitals, and
releasing more autonomous patients with a consequent
reduction of home care costs.
Table 2 Clinical trial phases in drug commercialization and motor rehabilitation
Phase Drug commercialization Studies on rehabilitation Purpose





To test concepts and related safety on
animals or on a small group of patients
Phase II Checking for efficacy
(on about 200 patients)
Development of Concept Trials
([15 patients)
To standardize the new intervention and
add a control group, randomization, and
masked outcomes. To establish the best
dose of therapy. To assess sample size
Phase
III
Confirmation of findings in large patient
population
([1000 patients for detecting rare side effects)
Demonstration of Concept Trials
(on a sample with a properly computed
size)







(multicenter randomized clinical trials)
To establish generalizable efficacy and
safety
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The proposed second law of neurorobotics, making the
robot perfectly obedient to the therapists’ requests, may
seem obvious, but it is not. Besides the above-mentioned
problems related to non-physiological gait patterns in
Lokomat-based therapy [57], another example of robot
‘‘disobedience’’ is the discrepancy between the desired and
actual values of some parameters of the electromechanical
Gait Trainer (as highlighted in [24]). The effective per-
centage of body weight supported by the machine is dif-
ferent from that selected in the initial static condition, since
the machine does not take into account the changes that
occur in the patient capacity to support their own weight
during training. Furthermore, the authors highlighted that
for Gait Trainer, the defined selector of walking speed is
actually a selector of step duration, and that the reported
speed coincides with the real one only if the maximum step
length has been also selected.
Robots should ‘‘disobey’’ clinicians’ orders only if their
sensors indicate that such orders lead to a potential risk for
the patient. This highlights the importance of sensors,
which is at the base of the adaptability and autonomy of
any robotic system [28]. In contrast, an electromechanical
device is not required to detect a potentially dangerous
choice by therapists due to wrong parameter tuning.
3.3 Third Law of Neurorobotics: Artificial
Intelligence as Support for Human Intelligence
The presence of a therapist in the loop (Fig. 1) allows
human control of the device, but the robot’s artificial
intelligence should not be limited to the safety control of
human decisions. During rehabilitation, there are many
parameters to calibrate, tune, and adapt. Firstly, the clini-
cian should always consider the effects of a parameter
change on other parameters. For example, to increase speed
during overground walking, a subject can reduce step
duration, increase step length, or both (usually at the same
time). In Lokomat-based training, when a therapist
increases the patient’s walking speed, they are actually
reducing the step duration without altering the step length,
since this parameter depends on the sagittal range of hip
motion; such changes in that hip range of motion need a
manual adjustment by the therapist. The handbook of
Hocoma [69] suggests that therapists should consider the
following points when increasing speed: (1) manually
adapt step length acting on hip range of motion controller
(the wider is the hip movement, the longer is the step); (2)
adjust the synchronization between treadmill and
exoskeleton speed (automatic setting is also possible); (3)
Fig. 1 Ideal patient-therapist-robot loop
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adjust the hip offset (not only range); (4) take into account
that foot impact could increase, and hence increase the load
on the joints; (5) check the quality of the movement that
may be affected by the change. This highlights how many
parameters are related to a simple change of speed in a
robot for gait training. Furthermore, speed is a parameter
with a very clear physiological meaning. More problems
could occur for a parameter for which it is not so easy to
understand its role, such as guidance force.
Robot artificial intelligence should be capable of auto-
matically performing all the control changes required by
the therapist, while providing them with a clear quantita-
tive overview of all these changes. The adoption of robotic
technologies for helping patients and therapists and quan-
titatively evaluating patient recovery is the main issue of
European projects such as MAAT (‘‘Multimodal interfaces
to improve therapeutic outcomes in robot-assisted reha-
bilitation’’, www.echord.info/wikis/website/maat) and
SYMBITRON (‘‘Symbiotic man–machine interactions in
wearable exoskeletons to enhance mobility for para-
plegics’’, www.symbitron.eu). These projects include the
patient in a symbiotic loop with the robot, similarly to what
we suggest in Fig. 1. Then, the therapist should simply be
required to qualitatively control patient performance under
the new conditions.
Summarising these concepts: a new generation of
human–machine interfaces integrated in neurorobots
should be developed, in which the therapist’s commands at
the macro level can be translated in micro changes
autonomously by the robot, which should inform the
therapist of these changes. However, there are no easy
ways to assess algorithmically whether the mutual patient-
robot adaptation is the optimal one for favouring the neu-
romotor recovery [57]. For this reason, the therapist should
be kept in the loop. In contrast with the robot, the therapist
has a qualitative but natural access to the health status of
the patient. For instance, they have detailed feedback of
feelings and sensations by dialoguing with the patient.
4 Conclusion
Most studies and reviews about robots for neurorehabili-
tation have focused on their effectiveness, but have found
inconsistent results. Little attention has been given to robot
ethics, probably because artificial intelligence is still
primitive. However, data shows that patients and therapists
are somewhat afraid of robots. Although we did not suggest
new technical solutions, in this review, we described the
state of the art of robots for neurorehabilitation, and sug-
gested a set of rules, which are a re-formulation of Asi-
mov’s three laws of robotics. We indicated the need for
these laws with many examples. The proposed three laws
of neurorobotics highlight the ethical need to prove a
robot’s effectiveness before commercialization, as well as
the desirable features that neurorobots should have. Fur-
thermore, we highlighted the need for including the ther-
apist in the loop between patient and robot. Finally, we
suggested that neurorobots can be a valuable tool in ther-
apists’ hands, helping them not only in repetitive and
intensive patient mobilization, but also providing quanti-
tative information about a patient’s deficits, residual abil-
ities, and functional recovery. We think that these three
laws should be considered from the first stages of neuro-
robot design. They may bring together engineers and
clinicians for the development of a new, effective genera-
tion of robots for neurorehabilitation.
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